Literature DB >> 24272058

Dose-dependent dual effect of corticosterone on cerebral 5-HT metabolism.

G L Kovács1, J Kishonti, K Lissák, G Telegdy.   

Abstract

The action of 1.0 and 10.0 mg/kg (i.p.) of corticosterone on serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) contents and on serotonin turnover, measured by an MAO-inhibitor method, was studied at 30 and 120 min after administration. A 1.0 mg/kg dose of corticosterone increased the serotonin content and turnover in the hypothalamus and mesencephalon 30 min after administration; however, it was ineffective on dorsal hippocampus and frontal and parietal cortex. 5-HIAA content did not change significantly in any of the brain areas studied. A 10.0 mg/kg dose of corticosterone decreased the serotonin content and turnover in the hypothalamus and mesencephalon; it was ineffective in other brain areas investigated. 5-HIAA content significantly decreased in the hypothalamus while it increased in the mesencephalon and dorsal hippocampus. In the parietal and frontal cortex, 5-HIAA content did not change following administration of 10.0 mg/kg of corticosterone. At 120 min after corticosterone administration, neither 5-HT content and turnover nor 5-HIAA content showed any change in the brain areas investigated. The results suggest that corticosteroids might change the activity of the brain serotoninergic system in a dose- and time-dependent manner, and in this way the serotoninergic system might play an important role in mediation of the corticosteroid effect exerted on brain function.

Entities:  

Year:  1977        PMID: 24272058     DOI: 10.1007/BF00969361

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  27 in total

1.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. 3. THE MONOAMINE NERVE TERMINAL.

Authors:  K FUXE
Journal:  Z Zellforsch Mikrosk Anat       Date:  1965-02-09

2.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. IV. DISTRIBUTION OF MONOAMINE NERVE TERMINALS IN THE CENTRAL NERVOUS SYSTEM.

Authors:  K FUXE
Journal:  Acta Physiol Scand Suppl       Date:  1965

3.  Dose-dependent action of corticosteroids on brain serotonin content and passive avoidance behavior.

Authors:  G L Kovács; G Telegdy; K Lissák
Journal:  Horm Behav       Date:  1977-04       Impact factor: 3.587

4.  The efferent connection of the nucleus raphe dorsalis.

Authors:  E T Pierce; W E Foote; J A Hobson
Journal:  Brain Res       Date:  1976-04-30       Impact factor: 3.252

5.  Dose-related dual action of corticosterone on hypothalamic serotonin content in rats.

Authors:  G L Kovács; G Telegdy; K Lissák
Journal:  Acta Physiol Acad Sci Hung       Date:  1975

6.  Effect of chronic administration of cortisone on the tryptophan induced changes in amine levels in the rat brain.

Authors:  N S Shah; S Stevens; H E Himwich
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-02

7.  Brain serotonin and pituitary-adrenal function.

Authors:  J Vernikos-Danellis; P Berger; J D Barchas
Journal:  Prog Brain Res       Date:  1973       Impact factor: 2.453

8.  Electrical stimulation of midbrain raphe: biochemical, behavioral and bioelectrical effects.

Authors:  W Kostowski; E Giacalone; S Garattini; L Valzelli
Journal:  Eur J Pharmacol       Date:  1969-08       Impact factor: 4.432

9.  Serotonin nerve terminals in adult rat neocortex.

Authors:  L Descarries; A Beaudet; K C Watkins
Journal:  Brain Res       Date:  1975-12-26       Impact factor: 3.252

10.  Inhibitory action of midbrain raphe stimulation on stress-induced elevation of plasma corticosterone level in rats.

Authors:  G L Kovács; J Kishonti; K Lissák; G Telegdy
Journal:  Neurosci Lett       Date:  1976-12       Impact factor: 3.046

View more
  1 in total

1.  Different regulation of serotonin receptors following adrenal hormone imbalance in the rat hippocampus and hypothalamus.

Authors:  M Martire; G Pistritto; P Preziosi
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.